1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Chronic Disease Market Trends

Global Hypertension Drugs Market 2016-2020

  • April 2016
  • 87 pages
  • Infiniti Research Limited
Report ID: 3794055

Summary

Table of Contents

About Hypertension Drugs

Hypertension, or high blood pressure (BP), develops when there is too much pressure against the inner walls of blood vessels. Depending on the pressure exerted, hypertension can be classified as:
- PAH
- Systemic hypertension (commonly referred to as hypertension)

PAH, high BP in the arteries that carry blood from the heart to the lungs, occurs when blood vessels narrow, making blood flow difficult. This creates pressure on the heart's right ventricle, which increases in size and becomes weaker due to the excess load, leading to heart failure. The normal pulmonary arterial pressure at rest is 14 mmHg and increases from 25 mmHg to 30 mmHg.
Systemic hypertension occurs when blood vessels that supply oxygenated blood to the body become narrower, creating pressure on the right side of the heart. Hypertension can lead to damaged organs and illnesses such as renal failure (kidney failure), aneurysm, heart failure, stroke, or heart attack. Hypertension is classified into two types:
- Primary or essential hypertension: It is defined as high BP with no known cause, and includes around 90%-95% of all hypertension cases
- Secondary hypertension: It is high BP with a known direct cause, including kidney disease, tumors, or birth control pills, and includes 5%-10% of all hypertension cases

Technavio’s analysts forecast the global hypertension drugs market to decline at a CAGR of (0.93) % during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the global hypertension drugs market for 201652020. To calculate the market size, the report considers the revenue generated from the sales of branded and generic drugs used to treat and prevent hypertension and pulmonary arterial hypertension (PAH).


The market is divided into the following segments based on geography:
- Americas
- EMEA
- APAC

Technavio's report, Global Hypertension Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the Key vendorsoperating in this market.

Key vendors
- Actelion Ltd.
- AstraZeneca plc
- Boehringer Ingelheim GmbH
- Daiichi Sankyo Company, Ltd.
- Novartis AG
- Sanofi SA


Other prominent vendors
- Actelion Pharmaceuticals
- Arena Pharmaceuticals
- Asahi Kasei
- Bayer HealthCare
- Bellerophon Therapeutics
- Bial
- CJ HealthCare
- Conatus Pharmaceuticals
- Daiichi Sankyo
- Deka Pharmaceuticals
- Dong-A ST
- Eiger BioPharmaceuticals
- Forest Laboratories
- Gilead Sciences
- HanAll BioPharma
- Hanmi Pharmaceutical
- Johnson & Johnson
- LG Life Sciences
- Lung Biotechnology
- Lupin Pharmaceuticals
- Mast Therapeutics
- Merck
- Northern Therapeutics
- Ono Pharmaceutical
- Pfizer
- PhaseBio
- Pluristem Therapeutics
- Quantum Genomics
- Radikal Therapeutics
- Reata Pharmaceuticals
- Serodus
- sigma-tau i.f.r
- SteadyMed Therapeutics
- Suda
- Sun Pharmaceutical Industries
- Symplmed Pharmaceuticals
- Takeda Pharmaceuticals
- United Therapeutics
- Valeant Pharmaceuticals
- XOMA
- Yuhan

Market driver
- Growing older population
- For a full, detailed list, view our report

Market challenge
- Patent expiries of major drugs
- For a full, detailed list, view our report

Market trend
- Increase in awareness
- For a full, detailed list, view our report

Key questions answered in this report
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Veronica helps you find the right report:

Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers
Hypertension Drugs Markets in China

Hypertension Drugs Markets in China

  • $ 4000
  • Industry report
  • May 2017
  • by Asia Market Information & Development Company

China’s demand for Hypertension Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth ...

Hypertension Drugs Industry Forecasts - China Focus

Hypertension Drugs Industry Forecasts - China Focus

  • $ 1800
  • Industry report
  • May 2017
  • by Asia Market Information & Development Company

This study focuses on China’s Hypertension Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities ...

Hypertension Drugs Companies in China

Hypertension Drugs Companies in China

  • $ 1800
  • Industry report
  • May 2017
  • by Asia Market Information & Development Company

This study focuses on China’s Hypertension Drugs industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.